George Tziras
Förmögenhet: 452 490 $ per 2026-08-31
Förmögenhet: 452 490 $ per 2026-08-31
George Tziras is currently Chief Executive Officer & Director at Small Pharma, Inc. since 2022, Non-Executive Director at Cybin UK Ltd. since 2015, and Chief Business Officer at Cybin, Inc. starting in 2025.
Formerly, Mr. Tziras was Chief Business Officer & Director at Unilock Capital Corp.
Education includes undergraduate studies at the University of Oxford and graduate studies at The Paul H.
Nitze School of Advanced International Studies.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
CYBIN, INC. 0,06 % | 2026-09-02 | 38 477 ( 0,06 % ) | 452 490 $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| SMALL PHARMA INC. | Verkställande Direktör | 2022-07-20 |
| CYBIN INC. | Investor Relations Kontakt | - |
Small Pharma Ltd.
Small Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops rapid-acting antidepressant | Direktör/Styrelseledamot | 2015-01-01 |
| Företag | Position | Slut |
|---|---|---|
| SMALL PHARMA INC. | Direktör/Styrelseledamot | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Paul H. Nitze School of Advanced International Studies
The Paul H. Nitze School of Advanced International Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Small Pharma Ltd.
Small Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops rapid-acting antidepressant | Health Technology |
Unilock Capital Corp.
Unilock Capital Corp. Financial ConglomeratesFinance Operates as a capital pool company | Finance |
Cybin, Inc.
Cybin, Inc. Pharmaceuticals: MajorHealth Technology Manufactures neurological pharmaceuticals | Health Technology |
Small Pharma, Inc.
Small Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a neuro pharmaceutical company that develops therapeutic treatments for mental health disorders | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån